Fig. 2From: Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspectiveTornado diagram. mRSÂ Modified Rankin Scale, HRÂ Hazard ratioBack to article page